[en] The performance of 10 pharmacokinetic models in predicting blood propofol concentrations was evaluated in patients during neurosurgical anesthesia. Eight patients—ASA category I or II, aged 49 ± 18-y-ears, weighing 71 ± 20 kg, and scheduled for routine neurosurgery—were anesthetized with propofol and sufentanil using Ohmeda pumps controlled with apersonal computer. Sufentanil was administered as a bolus of 0.3 μg kg-1, 5 min before induction of anesthesia, and infused at a constant rate of 0.5 μg·kg-1·h-1 throughout the study. At induction, propofol was administered as a bolus of 1.5 mg·kg-1 followed by a continuous infusion of 6 mg·kg-1·h-1. During surgery, the propofol infusion rate was deliberately increased by 2 mg·kg-1·h-1 every 15 min up to 12 mg·kg-1·h-1. Arterial blood samples were drawn at the end of each infusion step for measurement of propofol concentrations by high-performance liquid chromatography. Measured propofol concentrations were compared with theoretical concentrations derived from 10 published pharmacokinetic models designed in different clinical settings. Each model has been assessed by calculating the median of the performance error, the median of the absolute performance error, and their 10th and 90th percentiles. Models designed for certain categories, such as children, young, or elderly patients who received propofol as a bolus injection, showed a bad predictive accuracy. The models of Gepts et al. (AnesthAnalg 1987; 66:1256–1263,Anaesthesia 1988;43(suppl):8–13),Tackley et al. (Br J Anaesth 1989;62:46–53), and Cockshott (Postgrad Med J 1985;61:55), derived from healthy patients receiving continuous propofol infusions, provided the best agreement between expected and measured propofol concentrations; they showed bias and inaccuracy lower than 17%. In conclusion, the accurate prediction of blood propofol concentrations from different continuous infusion rates in ASA I or II patients requires the selection of appropriate pharmacokinetic models derived from similar categories of patients and using a similar technique of propofol administration. However, in clinical practice, the selection of a specific set among the appropriate models is balanced by the interindividual variability in blood propofol concentrations adjusted to clinical effects.
Richards MJ, Skues MA, Jarvis AP, Prys-Roberts C. Total i.v. anesthesia with propofol and alfentanil: dose requirements for propofol and the effect of premedication with clonidine. Br J Anaesth 1990; 65:157-63.
Raftery S, Enever G, Prys-Roberts C. Oesophageal contractility during total i.v. anesthesia with and without glycopyronium. Br J Anaesth 1991;66:566-72.
Browne BL, Prys-Roberts C, Wolf AR. Propofol and alfentanil in children: infusion technique and dose requirement for total i.v. anaesthesia. Br J Anaesth 1992;69:570-76.
Dunnet JM, Prys-Roberts C, Holland DE, Browne BL. Propofol infusion and the suppression of consciousness: dose requirements to induce loss of consciousness and to suppress response to noxious and non-noxious stimuli. Br J Anaesth 1994;72:29-34.
Schwilden H, Stoeckel H, Schuttler J. Closed-loop feedback of propofol anaesthesia by quantitative EEG analysis in humans. Br J Anaesth 1989;62:290-96.
Forrest FC, Tooley MA, Saunders PR, Prys-Roberts C. Propofol infusion and the suppression of consciousness: the EGG and dose requirements. Br J Anaesth 1994;72:35-41.
Van Hemelrijk J, Temp Elhoff R, White PF, Jellish WS. EEG assisted titration of propofol infusion during neuroanesthesia: effect of nitrous oxide. J Neurosurg Anesthesiol 1992;4:11-20.
Ravussin P, de Tribolet N. Total intravenous anesthesia with propofol for burst suppression in cerebral aneurysm surgery: preliminary report of 42 patients. Neurosurgery 1993;32:236-40.
Cantraine F, Cousseart E, d'Hollander A, Barvais L. MINA: monitoring of intravenous anaesthesia. A system to monitor the infusion of 4 intravenous drugs under the control of a personal computer. Int J Clin Monit Comput 1989;6:109-17.
Plummer GF. An improved method for the determination of propofol (ICI 35868) in blood. J Chromatogr B Biomed Appl 1987;421: 171-76.
Barvais L, Coussaert E, Cantraine F, d'Hollander A. The pharmacokinetics of intravenous anaesthetic drugs given by infusion: SPINA-a software program. Eur J Anaesthesiol 1989;6:435-47.
Cockshott ID. Propofol pharmacokinetis and metabolism - an overview. Postgrad Med J 1985;61:55.
Adam HK, Briggs LP, Bahar M, Douglas EJ, Dundee JW. Pharmacokinetic evaluation of ICI 35 868 in man. Br J Anaesth 1983;55: 97-103.
Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987;66:1256-63.
Gepts E, Jonckheer K, Maes V, Sonck W, Camu F. Disposition kinetics of propofol during alfentanil anaesthesia. Anaesthesia 1988; 43(supp):8-13.
Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF, Farinotti R. Pharmocokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 1988;69:887-91.
Tackley RM, Lewis GTR, Prys-Roberts C, Boaden RW, Dixon J, Harvey JT. Computer controlled infusion of propofol. Br J Anaesth 1989;62:46-53.
Sear JW, Glen JW. Propofol administered by a manual infusion regimen. Br J Anaesth 1995;74:362-67.
Coetzee JF, Glen JB, Wium, CA, Boshoff L. Pharmacokinetic model selection for target controlled infusions of propofol. Anesthesiology 1995;82:1328-45.
Saint-Maurice C, Cockshott ID, Douglas EJ, Richard MO, Harmey JL. Pharmacokinetics of propofol in young children after a single dose. Br J Anaesth 1989;63:667-70.
Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS. Pharmacokinetics of propofol (Diprivan) in elderly patients. Br J Anaesth 1988;60:146-50.